Citations

Mayo Clinic

Clear

2203 citation(s) found for "Ha, Ji Young".

MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification
Liu, Yu , He, Shuning , Durbin, Adam D. , Abraham, Brian J. , Easton, John , Shao, Ying , Xu, Beisi , Zhu, Shizhen , Li, Zhaodong , Weichert‐Leahey, Nina , Young, Richard A., Zhang, Jinghui , Look, A. Thomas , Zhang, Xiaoling , Xu, Beisi , Zimmerman, Mark W. , Zhang, Xiaoling , Young, Richard A

Cancer Discovery | December 28, 2017 | Volume: 8 | Issue: 3 | Pages: 320-335

10.1158/2159-8290.cd-17-0993 | PMID 29284669 Get It

Abstract The amplified MYCN gene serves as an oncogenic driver in approximately 20% of high-risk pediatric neuroblastomas. Here, we show that the family member MYC is a potent transforming gene in a separate subset of high-risk neuroblastoma cases (∼10%), based on (i) its upregulation by focal enhancer amplification or genomic rearrangements leading to enhancer hijacking, and (ii) its ability to transform neuroblastoma precursor cells in a transgenic animal model. The aberrant regulatory elements associated with oncogenic MYC activation include focally amplified distal enhancers and translocation of highly active enhancers from other genes to within topologically associating domains containing the MYC gene locus. The clinical outcome for patients with high levels of MYC expression is virtually identical to that of patients with amplification of the MYCN gene, a known high-risk feature of this disease. Together, these findings establish MYC as a bona fide oncogene in a clinically significant group of high-risk childhood neuroblastomas. Significance: Amplification of the MYCN oncogene is a recognized hallmark of high-risk pediatric neuroblastoma. Here, we demonstrate that MYC is also activated as a potent oncogene in a distinct subset of neuroblastoma cases through either focal amplification of distal enhancers or enhancer hijacking mediated by chromosomal translocation. Cancer Discov; 8(3); 320–35. ©2017 AACR. This article is highlighted in the In This Issue feature, p. 253
Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans
Delgado-Aros, Sílvia, Kim, Doe-Young, Burton, Duane D. , Thomforde, George M., Stephens, Debra, Camilleri, Michael , Thomforde, G. M., Brinkmann, Benjamin H. , Vella, Adrian

American Journal of Physiology-Gastrointestinal and Liver Physiology | December 24, 2017 | Volume: 282 | Issue: 3 | Pages: G424-G431

10.1152/ajpgi.2002.282.3.g424 | PMID 11841992 Get It

Glucagon-like peptide-1 (GLP-1) relaxes the stomach during fasting but decreases hunger and food consumption and retards gastric emptying. The interrelationships between volume, emptying, and postprandial symptoms in response to GLP-1 are unclear. We performed, in healthy human volunteers, a placebo-controlled study of the effects of intravenous GLP-1 on gastric volume using99mTc-single photon emission computed tomography imaging, gastric emptying of a nutrient liquid meal (Ensure) using scintigraphy, maximum tolerated volume (MTV) of Ensure, and postprandial symptoms 30 min after MTV. The role of vagal cholinergic function in the effects of GLP-1 was assessed by human pancreatic polypeptide (HPP) response to the Ensure meal. GLP-1 increased fasting and postprandial gastric volumes and retarded gastric emptying; MTV and postprandial symptoms were not different compared with controls. Effects on postprandial gastric function were associated with reduced postprandial HPP levels. GLP-1 does not induce postprandial symptoms despite significant inhibition of gastric emptying and vagal function; this may be partly explained by the increase in postprandial gastric volume.
Reserve capacity for ATP consumption during isometric contraction in human skeletal muscle fibers
Han, Young-Soo, Geiger, Paige C. , Han, Young Soo , Proctor, David N. , Sieck, Gary C.

Journal of Applied Physiology | December 23, 2017 | Volume: 90 | Issue: 2 | Pages: 657-664

10.1152/jappl.2001.90.2.657 | PMID 11160066 Get It

Maximum velocity of the actomyosin ATPase reaction ( VmaxATPase) and ATP consumption rate during maximum isometric activation (ATPiso) were determined in human vastus lateralis (VL) muscle fibers expressing different myosin heavy chain (MHC) isoforms. We hypothesized that the reserve capacity for ATP consumption [1 − (ratio of ATPisoto VmaxATPase)] varies across VL muscle fibers expressing different MHC isoforms. Biopsies were obtained from 12 subjects (10 men and 2 women; age 21–66 yr). A quantitative histochemical procedure was used to measure VmaxATPase. In permeabilized fibers, ATPisowas measured using an NADH-linked fluorometric procedure. The reserve capacity for ATP consumption was lower for fibers coexpressing MHC2Xand MHC2Acompared with fibers singularly expressing MHC2Aand MHCslow(39 vs. 52 and 56%, respectively). Tension cost (ratio of ATPisoto generated force) also varied with fiber type, being highest in fibers coexpressing MHC2Xand MHC2A. We conclude that fiber-type differences in the reserve capacity for ATP consumption and tension cost reflect functional differences such as susceptibility to fatigue.
Temporal aspects of excitation-contraction coupling in airway smooth muscle
Han, Young-Soo, Prakash, Y. S. , Prakash, Y S , Sieck, Gary C. , Han, Young Soo , Pabelick, Christina M.

Journal of Applied Physiology | December 22, 2017 | Volume: 91 | Issue: 5 | Pages: 2266-2274

10.1152/jappl.2001.91.5.2266 | PMID 11641370 Get It

In airway smooth muscle (ASM), ACh induces propagating intracellular Ca2+concentration ([Ca2+]i) oscillations (5–30 Hz). We hypothesized that, in ASM, coupling of elevations and reductions in [Ca2+]ito force generation and relaxation (excitation-contraction coupling) is slower than ACh-induced [Ca2+]ioscillations, leading to stable force generation. When we used real-time confocal imaging, the delay between elevated [Ca2+]iand contraction in intact porcine ASM cells was found to be ∼450 ms. In β-escin-permeabilized ASM strips, photolytic release of caged Ca2+resulted in force generation after ∼800 ms. When calmodulin (CaM) was added, this delay was shortened to ∼500 ms. In the presence of exogenous CaM and 100 μM Ca2+, photolytic release of caged ATP led to force generation after ∼80 ms. These results indicated significant delays due to CaM mobilization and Ca2+-CaM activation of myosin light chain kinase but much shorter delays introduced by myosin light chain kinase-induced phosphorylation of the regulatory myosin light chain MLC20and cross-bridge recruitment. This was confirmed by prior thiophosphorylation of MLC20, in which force generation occurred ∼50 ms after photolytic release of caged ATP, approximating the delay introduced by cross-bridge recruitment alone. The time required to reach maximum steady-state force was >15 s. Rapid chelation of [Ca2+]iafter photolytic release of caged diazo-2 resulted in relaxation after a delay of ∼1.2 s and 50% reduction in force after ∼57 s. We conclude that in ASM cells agonist-induced [Ca2+]ioscillations are temporally and spatially integrated during excitation-contraction coupling, resulting in stable force production.
Skeletal muscle force and actomyosin ATPase activity reduced by nitric oxide donor
Perkins, William J., Han, Young-Soo, Han, Young Soo , Sieck, Gary C.

Journal of Applied Physiology | December 22, 2017 | Volume: 83 | Issue: 4 | Pages: 1326-1332

10.1152/jappl.1997.83.4.1326 | PMID 9338443 Get It

Perkins, William J., Young-Soo Han, and Gary C. Sieck.Skeletal muscle force and actomyosin ATPase activity reduced by nitric oxide donor. J. Appl. Physiol.83(4): 1326–1332, 1997.—Nitric oxide (NO) may exert direct effects on actin-myosin cross-bridge cycling by modulating critical thiols on the myosin head. In the present study, the effects of the NO donor sodium nitroprusside (SNP; 100 μM to 10 mM) on mechanical properties and actomyosin adenosinetriphosphatase (ATPase) activity of single permeabilized muscle fibers from the rabbit psoas muscle were determined. The effects of N-ethylmaleimide (NEM; 5–250 μM), a thiol-specific alkylating reagent, on mechanical properties of single fibers were also evaluated. Both NEM (≥25 μM) and SNP (≥1 mM) significantly inhibited isometric force and actomyosin ATPase activity. The unloaded shortening velocity of SNP-treated single fibers was decreased, but to a lesser extent, suggesting that SNP effects on isometric force and actomyosin ATPase were largely due to decreased cross-bridge recruitment. The calcium sensitivity of SNP-treated single fibers was also decreased. The effects of SNP, but not NEM, on force and actomyosin ATPase activity were reversed by treatment with 10 mMdl-dithiothreitol, a thiol-reducing agent. We conclude that the NO donor SNP inhibits contractile function caused by reversible oxidation of contractile protein thiols.
Building a Healthy Body After Cancer: Young Adult Lymphoma Survivors' Perspectives on Exercise After Cancer Treatment
Kimball, Brittany , Asiedu, Gladys B. , Thompson, Carrie A. , Kimball, Brittany C, Kimball, Brittany C

Journal of Adolescent and Young Adult Oncology | December 22, 2017 | Volume: 7 | Issue: 2 | Pages: 217-229

10.1089/jayao.2017.0093 | PMID 29272188 Get It

Acute kidney injury impact on inpatient mortality in Clostridium difficile infection: A national propensity‐matched study
Charilaou, Paris , Devani, Kalpit , John, Febin , Kanna, Sowjanya, Ahlawat, Sushil , Young, Mark , Khanna, Sahil , Reddy, Chakradhar

Journal of Gastroenterology and Hepatology | December 5, 2017 | Volume: 33 | Issue: 6 | Pages: 1227-1233

10.1111/jgh.14064 | PMID 29205514 Get It

AbstractBackground and AimAcute kidney injury (AKI) is used as a marker of severity in Clostridium difficile infection (CDI) patients. We estimated the true effect of AKI in inpatient mortality of CDI patients, as there are no large‐scale, population‐based, propensity‐matched studies evaluating AKI's effect in this patient cohort.MethodsA retrospective observational study utilizing the National Inpatient Sample from years 2003 to 2012, including all adults with CDI, excluding cases missing data on age, inpatient mortality or gender. Trends and CDI‐related complications as mortality predictors were assessed using survey‐weighted multivariable regression. We estimated AKI's independent effect by propensity‐matching, post‐stratifying by chronic kidney disease status, allowing for multiple comorbidity adjustment.ResultsA total of 2 859 599 patients with CDI were included, of which 896 122 (31.3%) had principal diagnosis of CDI. AKI prevalence was 22%. Mortality rate was 8.4%, while among AKI patients was higher (18.2%). In multivariable regression, AKI was associated with higher mortality (odds ratio [OR] = 3.16, 95% confidence interval [CI]: 3.02–3.30; P < 0.001), while after propensity matching, AKI increased mortality by 86% (OR = 1.86, 95% CI: 1.79–1.94; P < 0.001). CDI incidence increased by 1.8, together with the rate of AKI (12.6% in 2003 to 28.8% in 2012, P‐trend < 0.001). Despite increasing hospitalizations, mortality over the study period decreased to 7.2% (2012) from 9.0% (2003); P‐trend < 0.001.ConclusionHospital admissions of patients with CDI and concomitant AKI are increasing, but their inpatient mortality has improved over the study period. AKI is a significant contributor to mortality, independently of other comorbidities, complications, and hospital characteristics, emphasizing the need for early diagnosis and aggressive management in such patients.
Cardiac MR elastography using reduced‐FOV, single‐shot, spin‐echo EPI
Sui, Yi , Arunachalam, Shivaram P. , Arani, Arvin , Trzasko, Joshua D. , Young, Phillip M. , Glockner, James F., Glaser, Kevin J. , Lake, David S. , McGee, Kiaran P. , Rossman, Phillip J. , Araoz, Philip A. , Arunachalam, S P , Arani, Arvin , Manduca, Armando , Ehman, Richard L. , Sui, Yi

Magnetic Resonance in Medicine | December 1, 2017 | Volume: 80 | Issue: 1 | Pages: 231-238

10.1002/mrm.27029 | PMID 29194738 Get It

PurposeTo implement a reduced field of view (rFOV) technique for cardiac MR elastography (MRE) and to demonstrate the improvement in image quality of both magnitude images and post‐processed MRE stiffness maps compared to the conventional full field of view (full‐FOV) acquisition.MethodsWith Institutional Review Board approval, 17 healthy volunteers underwent both full‐FOV and rFOV cardiac MRE scans using 140‐Hz vibrations. Two cardiac radiologists blindly compared the magnitude images and stiffness maps and graded the images based on several image quality attributes using a 5‐point ordinal scale. Fisher's combined probability test was performed to assess the overall evaluation. The octahedral shear strain‐based signal‐to‐noise ratio (OSS‐SNR) and median stiffness over the left ventricular myocardium were also compared.ResultsOne volunteer was excluded because of an inconsistent imaging resolution during the exam. In the remaining 16 volunteers (9 males, 7 females), the rFOV scans outperformed the full‐FOV scans in terms of subjective image quality and ghosting artifacts in the magnitude images and stiffness maps, as well as the overall preference. The quantitative measurements showed that rFOV had significantly higher OSS‐SNR (median: 1.4 [95% confidence interval (CI): 1.2–1.5] vs. 2.1 [95% CI: 1.8–2.4]), P < 0.05) compared to full‐FOV. Although no significant change was found in the median myocardial stiffness between the 2 scans, we observed a decrease in the stiffness variation within the myocardium from 2.1 kPa (95% CI: [1.9, 2.3]) to 1.9 kPa (95% CI: [1.7, 2.0]) for full‐FOV and rFOV, respectively (P < 0.05) in a subgroup of 7 subjects with ghosting present in the myocardium.ConclusionThis pilot volunteer study demonstrated that rFOV cardiac MRE has the capability to reduce ghosting and to improve image quality in both MRE magnitude images and stiffness maps. Magn Reson Med 80:231–238, 2018. © 2017 The Authors Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in Medicine. This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
A mutational comparison of adult and adolescent and young adult (AYA) colon cancer
Tricoli, James V. , Boardman, Lisa A. , Patidar, Rajesh , Jang, Jin Sung , Walsh, William D., McGregor, Paul M., Camalier, Corinne E., Mehaffey, Michele G., Furman, Wayne L. , Bahrami, Armita , Lih, Chih‐Jian, Conley, Barbara A. , Khan, Javed , Jang, Jin S, Boardman, Lisa , Sindiri, Sivasish , Williams, P. Mickey

Cancer | November 30, 2017 | Volume: 124 | Issue: 5 | Pages: 1070-1082

10.1002/cncr.31136 | PMID 29194591 Get It

BACKGROUND It is possible that the relative lack of progress in treatment outcomes among adolescent and young adult (AYA) patients with cancer is caused by a difference in disease biology compared with the corresponding diseases in younger and older individuals. There is evidence that colon cancer is more aggressive and has a poorer prognosis in AYA patients than in older adult patients. METHODS To further understand the molecular basis for this difference, whole‐exome sequencing was conducted on a cohort of 30 adult, 30 AYA, and 2 pediatric colon cancers. RESULTS A statistically significant difference in mutational frequency was observed between AYA and adult samples in 43 genes, including ROBO1 , MYC binding protein 2 ( MYCBP2 ), breast cancer 2 (early onset) ( BRCA2 ), MAP3K3, MCPH1, RASGRP3, PTCH1, RAD9B, CTNND1, ATM, NF1 ; KIT, PTEN , and FBXW7 . Many of these mutations were nonsynonymous, missense, stop‐gain, or frameshift mutations that were damaging. Next, RNA sequencing was performed on a subset of the samples to confirm the mutations identified by exome sequencing. This confirmation study verified the presence of a significantly greater frequency of damaging mutations in AYA compared with adult colon cancers for 5 of the 43 genes ( MYCBP2, BRCA2, PHLPP1, TOPORS , and ATR ). CONCLUSIONS The current results provide the rationale for a more comprehensive study with a larger sample set and experimental validation of the functional impact of the identified variants along with their contribution to the biologic and clinical characteristics of AYA colon cancer. Cancer 2018;124:1070‐82. © 2017 American Cancer Society .
Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma
Ferrufino‐Schmidt, María C. , Medeiros, L. Jeffrey , Liu, Hui , Clemens, Mark W. , Laurent, Camille , Lofts, Julian , Amin, Mitual , Chai, Siaw Ming , Morine, Angela, Napoli, Arianna Di , Bhagat, Govind , Tritz, Denise, Quesada, Andres , Hu, Qinlong, Gómez, Francisco Javier García , Martín, Juan José Borrero , Thakral, Beenu , Narbaitz, Marina, Hughes, R. Condon, Yang, Li-Jun, Fromm, Jonathan R. , Wu, David , Sohani, Aliyah R. , Vadlamani, Indira U., Ferry, Judith A. , Szigeti, Réka , Tardío, Juan C. , Granados, Rosario , Dertinger, Susanne, Offner, Felix, Pircher, Andreas , Hosry, Jeff , Miranda, Roberto N. , Horna, Pedro , Di Napoli, Arianna , Hunt, Kelly K. , Doǧan, Ahmet , Parkash, Vinita , Piña‐Oviedo, Sergio , Zhang, Da , Hunt, John, Vadlamani, Indira, Morgan, Elizabeth A. , Young, Ken H. , Medeiros, L Jeffrey , Bhagat, Govind , Miranda, Roberto N

American Journal of Surgical Pathology | November 29, 2017 | Volume: 42 | Issue: 3 | Pages: 293-305

10.1097/pas.0000000000000985 | PMID 29194092 Get It

Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a rare T-cell lymphoma that arises around breast implants. Most patients manifest with periprosthetic effusion, whereas a subset of patients develops a tumor mass or lymph node involvement (LNI). The aim of this study is to describe the pathologic features of lymph nodes from patients with BI-ALCL and assess the prognostic impact of LNI. Clinical findings and histopathologic features of lymph nodes were assessed in 70 patients with BI-ALCL. LNI was defined by the histologic demonstration of ALCL in lymph nodes. Fourteen (20%) patients with BI-ALCL had LNI, all lymph nodes involved were regional, the most frequent were axillary (93%). The pattern of involvement was sinusoidal in 13 (92.9%) cases, often associated with perifollicular, interfollicular, and diffuse patterns. Two cases had Hodgkin-like patterns. The 5-year overall survival was 75% for patients with LNI and 97.9% for patients without LNI at presentation (P=0.003). Six of 49 (12.2%) of patients with tumor confined by the capsule had LNI, compared with LNI in 8/21 (38%) patients with tumor beyond the capsule. Most patients with LNI achieved complete remission after various therapeutic approaches. Two of 14 (14.3%) patients with LNI died of disease compared with 0/56 (0%) patients without LNI. Twenty percent of patients with BI-ALCL had LNI by lymphoma, most often in a sinusoidal pattern. We conclude that BI-ALCL beyond capsule is associated with a higher risk of LNI. Involvement of lymph nodes was associated with decreased overall survival. Misdiagnosis as Hodgkin lymphoma is a pitfall.